| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.3M | +12.4% |
| SG&A Expense | $3.7M | -66.0% |
| Operating Income | -$7.9M | +49.7% |
| Net Income | -$8.9M | +46.6% |
| EPS (Basic) | -$0.09 | +35.7% |
| EPS (Diluted) | -$0.09 | +35.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.0M | -51.9% |
| Current Assets | $3.1M | -51.2% |
| Total Assets | $3.3M | -49.3% |
| Current Liabilities | $41.1M | +8.2% |
| Stockholders' Equity | -$37.8M | -20.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | +3.2% |
| Investing Cash Flow | -$1K | +90.0% |
| Financing Cash Flow | $3.7M | -50.1% |